ТHE IMPACT OF THE PROPOSED THERAPEUTIC AND PREVENTIVE COMPLEX ON THE HEMOSTASIS SYSTEM, ENDOTHELIAL, AND IMMUNE STATUS IN PREGNANT WOMEN FOLLOWING ASSISTED REPRODUCTIVE TECHNOLOGIES

Authors

DOI:

https://doi.org/10.11603/24116-4944.2024.2.14987

Keywords:

pregnancy, miscarriage, childbirth, perinatal outcomes, endothelial dysfunction, assisted reproductive technologies

Abstract

The aim of the study – to determine the state of the hemostasis system and endothelial factors in women after the use of assisted reproductive technologies (ART) based on the proposed therapeutic and preventive complex.

Materials and Methods. A prospective study was conducted involving 299 pregnant women, categorized according to the type of infertility and management approach: Group I – 94 women with tubal-peritoneal infertility. Group II – 87 women with endocrine infertility. Group III – 68 women with male-factor infertility. Control group – 50 pregnant women with spontaneous conception and physiological pregnancy progression. Depending on the treatment approach, Subgroup A included pregnant women who received the proposed therapeutic complex, while Subgroup B – pregnant women treated according to standard obstetric care protocols. Therefore, Subgroup IA included 49 women, Subgroup IB – 45 women, Subgroup IIA – 48 women, Subgroup IIB – 39 women, Subgroup IIIA – 36 women, Subgroup IIIB – 32 women. Blood samples were taken from the cubital vein to assess homocysteine levels (ELISA, AXIS-SHIELD reagents, UK; Stat Fax 2100 analyzer, USA), coagulogram parameters (four-channel coagulation analyzer Coag 4D, Diagon, Hungary), Endothelin-1 (ELISA, Biomedica reagents, UK; Stat Fax 2100 analyzer, USA), VEGF levels (ELISA, Biotin Conc reagents, UK; Stat Fax 2100 analyzer, USA). The proposed therapeutic and preventive complex included progesterone support, magnesium supplementation, folic acid, L-arginine aspartate, omega-3 polyunsaturated fatty acids, long-term psychological correction.

Results and Discussion. The proposed therapeutic and diagnostic complex demonstrated positive effects by influencing:

  1. a) homocysteine concentration – a significant reduction in homocysteine levels in subgroup A compared to subgroup B (e.g., IA: 8.2±1.4 mmol/L vs. IB: 20.3±1.8 mmol/L, p<0.05). Reduction in miscarriage risk in Group I by 41.6% (Group I before treatment: 70.2%; subgroup IA: 28.6%, p<0.05). Decreased spontaneous miscarriage cases in Group I (subgroup IA: 28.6%, subgroup IB: 57.7%, p<0.05).
  2. b) coagulation hemostasis – normalization of fibrinogen levels (IA: 3.2±0.2 g/L, IB: 4.1±0.1 g/L, p<0.05), reduced D-dimer (IA: 241.5±11.6 ng/mL, IB: 517.3±12.1 ng/mL, p<0.05), decreased soluble fibrin monomer complexes (RFMK) (IA: 0.39±0.2, IB: 0.55±0.1, p<0.05).
  3. c) endothelial status – lower VEGF levels (e.g., IA: 38.4±6.1 pg/mL, IB: 321.8±14.6 pg/mL, p<0.05), reduced endothelin-1 levels (e.g., IA: 2.6±0.4 ng/mL, IB: 17.1±3.2 ng/mL, p<0.05).
  4. d) immune status – improved cellular homeostasis: reduced T-lymphocytes (IA: 0.39±0.04, IB: 0.70±0.13, p<0.05), decreased CD3+ levels (IA: 28.24±1.31, IB: 34.89±1.29, p<0.05), increased CD8+ levels (IA: 17.24±0.33, IB: 14.76±0.34, p<0.05). Enhanced humoral homeostasis: mnormalized B-lymphocyte levels (IA: 28.22±0.61, IB: 24.28±0.9, p<0.05), restored CD22+ cell levels (IA: 0.41±0.02×109/L, IB: 0.52±0.04×109/L, p<0.05).

Conclusions. The proposed therapeutic and diagnostic complex is an effective method for correcting endothelial, hemostatic, and immune status abnormalities in pregnant women after ART. It is recommended for practical use in this group of patients.

Author Biographies

L. M. Vygivska, Bogomolets National Medical University

MD, PhD, Doctoral Student

I. V. Maidannyk, Bogomolets National Medical University

MD, PhD, Associate Professor

O. O. Chorna, Bogomolets National Medical University

MD, PhD, Associate Professor

N. М. Hychka, Bogomolets National Medical University

MD, PhD, Associate Professor, Department of Obstetrics and Gynecology No.3

V. M. Komar, Bogomolets National Medical University

assistant, department obstetrics and gynecology №3

K. V. Kolyvanova, Bogomolets National Medical University

Obstetrician-Gynecologist

References

Maslo, D. (2016). Optymizatsiia taktyky vedennia vahitnosti ta polohiv u zhinok pislia zastosuvannia dopomizhnykh reproduktyvnykh tekhnolohii [Optimization of the tactics of maintaining the importance of women's positions after the use of assisted reproductive technologies]. Zdorove zhenshchyny – Health of a woman, (5), 160-164 [in Ukrainian].

Rubinstein, A. (2022). Taktyka vedennya vahitnosti, polohiv ta pislyapolohovoho periodu u patsiyentok piznʹoho reproduktyvnoho viku z vahitnistyu, yaka nastala za dopomohoyu dopomizhnykh reproduktyvnykh tekhnolohiy [Management of pregnancy, delivery, and postpartum in patients of advanced maternal age with pregnancies obtained by assisted reproductive technologies]. Reproduktyvne zdorovya zhinky – Reproductive Health of Woman, (4), 16–22 [in Ukrainian]. DOI: https://doi.org/10.30841/2708-8731.4.2022.262761

Golyanovskiy О., Zukin, V., Shemyakina, N., & Rubinshtein A. (2021). Osoblyvosti perebihu vahitnosti, polohiv ta pislyapolohovoho periodu na tli zastosuvannya dopomizhnykh reproduktyvnykh tekhnolohiy [Features of pregnancy, delivery and postpartum on the background of assisted reproductive technologies]. Reproduktyvne zdorovya zhinky – Reproductive Health of Woman, (9-10), 79–87 [in Ukrainian]. DOI: https://doi.org/10.30841/2708-8731.9-10.2021.252598

Nevyshnа Y. (2021). Suchasni pohlyady na profilaktyku akushersʹkykh ta perynatalʹnykh uskladnenʹ u zdorovykh vahitnykh: ohlyad literatury [Modern views on the prevention of obstetric and perinatal complications in healthy pregnant women: literature review]. Reproduktyvne zdorovya zhinky – Reproductive Health of Woman, (1), 49-53 [in Ukrainian]. DOI: https://doi.org/10.30841/2708-8731.1.2021.229715

Andriichuk, T., Senchuk, A., & Chermak, V. (2021). Stan systemy maty–platsenta–plid u vahitnykh iz obtyazhenym hinekolohichnym anamnezom [Condition of the mother–placenta–fetal system in pregnant women with a general gynecological anamnesis]. Reproduktyvne zdorovya zhinky – Reproductive Health of Woman, (1), 70–74 [in Ukrainian]. DOI: https://doi.org/10.30841/2708-8731.1.2021.229719

Seliukova, N. Yu., Kustova, S., Boiko, M., Brechka, N., Korenieva, Ye. & Mysiura, K. (2019). Platsentarna nedostatnistʹ: stan problemy ta zasoby rannʹoyi profilaktyky yiyi naslidkiv [Placentar insufficiency: state of problem and early prophylactic effects]. Odeskyi medychnyi zhurnal – Odessa medical journal, (3), 40-45 [in Ukrainian].

Qu, H., & Khalil, R. A. (2020). Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. Am J Physiol Heart Circ Physiol, 319(3), H661-H681. DOI: https://doi.org/10.1152/ajpheart.00202.2020

Linnikov V., & Linnikov S. (2019). Trombofiliya yak klyuchova lanka patohenezu uskladnenʹ v akusherstvi ta hinekolohiyi [Trombophilia as the main link of pathogenesis of complications in obstetrics and gynecology]. Science and Education, (3), 31-36 [in Ukrainian]. DOI: https://doi.org/10.24195/2414-4665-2019-3-5

Guo J., Feng, Q., Chaemsaithong, P. et al. (2023). Biomarkers at 6 weeks' gestation in the prediction of early miscarriage in pregnancy following assisted reproductive technology. Acta Obstet Gynecol Scand, 102(8), 1073-1083. DOI: https://doi.org/10.1111/aogs.14618

Boichuk, A. V., Ovcharuk, V. V., & Khlibovska, O. I. (2017). Diahnostyka i korektsiia porushen u vahitnykh iz dysfunktsiieiu platsenty [Diagnosis and correction of disorders in pregnant women with placental dysfunction.]. Akusherstvo. Hinekolohiia. Henetyka – Obstetrics. Gynecology. Genetics, 3 (2), 5-7 [in Ukrainian].

Borzenko, I. B. (2020). Prohnozuvannya ta rannya diahnostyka zatrymky rostu ploda u vahitnykh iz platsentarnoyu dysfunktsiyeyu [Prediction and early diagnosis of fetal growth retardation in pregnant women with placental dysfunction]. Doctoral dissertation [in Ukrainian].

Golyanovsky O., Morozova O., & Frolov S. (2023). Hiperhomotsysteyinemiya yak marker akushersʹkoyi patolohiyi [Hyperhomocysteinemia as a marker of obstetric pathology]. Reproduktyvne zdorovya zhinky – Reproductive Health of Woman, (3), 52-59 [in Ukrainian].

MOZ Ukrainy [Ministry of Health of Ukraine]. (2022). Fiziolohichni polohy [Physiological childbirth]. Order No 170 dated 26.01.2022 [in Ukrainian].

MOZ Ukrainy [Ministry of Health of Ukraine]. (2013). Pro zatverdzhennia Instruktsii pro poriadok zastosuvannia dopomizhnykh reproduktyvnykh tekhnolohiy [On approval of the Instructions on the procedure for the use of assisted reproductive technologies] . Order No 787 dated 09.09.2013 [in Ukrainian].

Romero, R., Conde-Agudelo, A., Da Fonseca E. et al. (2018) Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol, 218(2), 161-180. DOI: https://doi.org/10.1016/j.ajog.2017.11.576

Babenko V., Mokiienko A., Levkovska V. Yu. (2022). Biostatystyka. Navchalno-metodychnyi posibnyk [Biostatistics. A textbook]. Odesa. [in Ukrainian].

Published

2025-01-22

How to Cite

Vygivska, L. M., Maidannyk, I. V., Chorna, O. O., Hychka N. М., Komar, V. M., & Kolyvanova, K. V. (2025). ТHE IMPACT OF THE PROPOSED THERAPEUTIC AND PREVENTIVE COMPLEX ON THE HEMOSTASIS SYSTEM, ENDOTHELIAL, AND IMMUNE STATUS IN PREGNANT WOMEN FOLLOWING ASSISTED REPRODUCTIVE TECHNOLOGIES. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 32–37. https://doi.org/10.11603/24116-4944.2024.2.14987

Issue

Section

OBSTETRICS AND GYNECOLOGY